H Ames - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

H Ames

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

HIV Clinical Trials|October 31, 2002

Lamivudine 300 mg QD versus continued lamivudine 150 mg BID with stavudine and a protease inhibitor in suppressed patientsMichael G Sension, Nicholaos C Bellos, Judy Johnson, et al.

Neurology|July 9, 2008

Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraineS D Silberstein, L K Mannix, J Goldstein, et al.

The Journal of Clinical Endocrinology and Metabolism|February 25, 2022

The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi SyndromeJennifer L Miller, André Lacroix, Lynne M Bird, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

HIV Clinical Trials|October 31, 2002

Lamivudine 300 mg QD versus continued lamivudine 150 mg BID with stavudine and a protease inhibitor in suppressed patientsMichael G Sension, Nicholaos C Bellos, Judy Johnson, et al.

Neurology|July 9, 2008

Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraineS D Silberstein, L K Mannix, J Goldstein, et al.

The Journal of Clinical Endocrinology and Metabolism|February 25, 2022

The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi SyndromeJennifer L Miller, André Lacroix, Lynne M Bird, et al.

Pageof 3